Inspira™ Technologies Reports First Quarter 2023 Financial Results
Boekel Scientific Introduces New Family of Digital Forced Air Incubators
Navrogen Announces Publication of NAV-001 Antibody-Drug Conjugate Development and Efficacy in Humoral Immunosuppressed Cancers
BUILT EXPANDS PROTEIN-PACKED LINEUP WITH NEW WAYS TO SNACK FOR ANY OCCASION
Primrose Schools® Enters Midyear with Additions to C-Suite and 23 New Franchise Agreements Awarded
America’s Best Wings: Everything You Need to Know
Seissan hunters are trained in lifesaving gestures
A new monitoring tool? Human DNA captured from the environment
heavy; Fabrice and Briac from Beijing Express in the Marian city for the fight against cancer
Music to “cure” illnesses: a lucrative fashion without scientific basis
Understanding and preventing miscarriages with a blood test
As of March 31, 2023, the Company had $11.5 million in cash, cash equivalents, and short-term bank deposits RA’ANANA, Israel, May 18, 2023 /PRNewswire/ — Inspira...